NORS^TM – Introducing a new patented platform technology – a first-line non-antibiotic antimicrobial to help fight drug resistant infections and pandemics

SaNOtize Research and Development Corp., is a rapidly growing pharmaceutical company focused on developing and commercializing high quality, innovative products.

We aim to improve the quality of life for people throughout the world by using our proprietary biotechnology platform to remedy topical infections that negatively impact quality of life. Therapeutic targets include SARS-COV-2 (COVID-19), influenza, onychomycosis (nail fungus), chronic sinusitis, diabetic foot ulcers and others.